Risk Assessment in the Genomic Era

Toxicologic Pathology

Volumn 32, Issue SUPPL. 1, 2004, Pages 3-8

  Cohen, Samuel M ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Carcinogenesis; Dose response; Genetics; Species extrapolation; Toxicity

Indexed keywords

BIOLOGICAL MARKER; TOXIC SUBSTANCE;

ARTICLE; BIOCHEMISTRY; CANCER GENETICS; CHEMISTRY; DNA SEQUENCE; DOSE RESPONSE; GENETIC SUSCEPTIBILITY; GENOMICS; HUMAN; KNOCKOUT MOUSE; NONHUMAN; PATHOLOGY; PHARMACOLOGY; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING; TOXICITY; TOXICOKINETICS; TOXICOLOGY; TRANSGENIC MOUSE; TWINS;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENOMICS; HUMANS; RISK ASSESSMENT; SPECIES SPECIFICITY; TOXICITY TESTS; TOXICOLOGY;

MUS MUSCULUS;

EID: 1842510721     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1080/01926230490424969     Document Type: Article

References (30)

1. Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., Powell, J. I., Yang, L., Marti, G. E., Moore, T., Hudson, Jr. J., Lu, L., Lewis, D. B., Tibshirani, R., Sherlock, G., Chan, W. C., Greiner, T. C., Weisenburger, D. D., Armitage, J. O., Warnke, R., Levy, R., Wilson, W., Grever, M. R., Byrd, J. C., Botstein, D., Brown, P. O., and Staudt, L. M. (2000). Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 405, 503-11.
2. Andersen, M. E., Meed, E., Boorman, G. A., Brusick, D. J., Cohen, S. M., Dragan, Y. P., Frederick, C. B., Goodman, J. I., Hard, G. C., O'Flaherty, E. J., and Robinson, D. E. (2000). Lessons learned in applying the U.S. EPA's proposed cancer guidelines to specific compounds. Toxicol Sci 53, 159-72.
3. Beland, F. A., Fullerton, N. F., Kinouchi, T., and Poirier, M. C. (1988). DNA Adduct Formation During Continuous Feeding of 2-Acetylaminofluorene at Multiple Concentrations. In Methods for Detecting DNA Damaging Agents in Humans: Applications in Cancer Epidemiology and Prevention (H. Bartsch, K. Hemminki, and I. K. O'Neill, eds.), 89th Ed., pp. 175-80. Lyon, France, IARC Scientific Publications.
4. Box, G. E. P., (1979). Robustness in the Strategy of Scientific Model Building. In Robustness in Statistics (R. L. Launer and G. N. Wilkinson, eds.). Academic Press, New York.
5. Burin, G. J., Gibb, H. J., and Hill, R. N. (1995). Human bladder cancer: evidence fora potential irritation-induced mechanism. Fd Chem Toxicol 33, 785-95.
6. Clayson, D. B., Fishbein, L., and Cohen, S. M. (1995). The effect of stones and other physical factors on the induction of rodent bladder cancer. Fd Chem Toxicol 33, 771-84.
7. Cohen, S. M. (1998). Cell proliferation and carcinogenesis. Drug Metabol Rev 30, 339-57.
8. Cohen, S. M. (2001). Alternative models for carcinogenicity testing: weight of evidence evaluation across models. Toxicol Pathol 29(Suppl), 183-90.
9. Cohen, S. M., and Ellwein, L. B. (1990a). Cell proliferation in carcinogenesis. Science 249, 1007-11.
10. Cohen, S. M., and Ellwein, L. B. (1990b). Proliferative and genotoxic cellular effects in 2-acetylaminofluorene bladder and liver carcinogenesis: biological modeling of the ED01 study. Toxicol Appl Pharmacol 104, 79-93.
11. Cohen, S. M., and Ellwein, L. B. (1991). Genetic errors, cell proliferation, and carcinogenesis. Perspectives. Cancer Res 51, 6493-505.
12. Cohen, S. M., and Hill, R. N. (2003). Urinary bladder tumors associated with exposure to melamine. Crit Rev Toxicol 33, 632-9.
13. Constan, A. A., Sprankle, C. S., Everitt, J. I., Wong, B. A., Gonzalez, F. L., and Butterworth, B. E. (1999). Metabolism of chloroform by cytochrome P450 2E1 is required for induction of toxicity in the liver kidney, and nose of male mice. Toxicol Appl Pharmacol 160, 120-6.
14. DeSesso, J. M. (1995). Anatomical relationships of urinary bladders compared: their potential role in the development of bladder tumours in humans and rats. Fd Chem Toxicol 33, 705-14.
15. 2U-globulin is necessary for D-limonene promotion of male rat kidney tumors. Cancer Res 51, 3512-21.
16. Gold, P., and Freedman, S. O. (1965). Specific carcinoembryonic antigens of the human digestive system. J Exp Med 122, 467-81.
17. Gulezian, D., Jacobson-Krem, D., McCullough, C. B., Olson, H., Recio, L., Robinson, D., Storer, R., Tennant, R., Ward, J. M., and Neumann, D. A. (2000). Use of transgenic animals for carcinogenicity testing: considerations and implications for risk assessment. Toxicol Pathol 28, 482-99.
18. Hans, C. P., Weisenburger, D. D., Greiner, T. C., Gascoyne, R. D., Delabie, J., Ott, G., Müller-Hermelink, H. K., Braziel, R. M., Jaffe, E. S., Pan, Z., Farinha, P., Smith, L. M., Falini, B., Banham, A. H., Rosenwald, A., Staudt, L. M., Connors, J. M., Armitage, J. O., and Chan, W. C. (2004). Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103, 275-82.
19. IARC Working Group (1999). Consensus Report. International Agency for Research on Cancer, IARC Scientific Publications 147, 1-32.
20. 2U-globulin) male rat kidney tumors associated with exposure to D-limonene. Crit Rev Toxicol 33, 611-4.
21. Lichtenstein, P., Holm, N. V., Verkasalo, P. K., Iliadou, A., Kaprio, J., Kosekenvuo, M., Pukkala, E., Skythe, A., and Hemminki, K. (2000). Environmental and heritable factors in the causation of cancer. New Engl J Med 343, 78-85.
22. Meek, M. E. (2003). Kidney and liver tumours associated with chloroform exposure. Crit Rev Toxicol 33, 625-32.
23. Meek, M. E., Bucher, J. R., Cohen, S. M., Dellarco, V., Hill, R. N., Lehman-McKeeman, L. D., Longfellow, G. D., Pastoor, T., Seed, J., and Patton, D. E. (2003). A framework for human relevance analysis of information on carcinogen modes of action. Crit Rev Toxicol 33, 591-653.
24. Paules, R. (2003). Phenotypic anchoring: linking cause and effect. Environ Hlth Perspect 111, A338-9.
25. Peters, J. M., Cattley, R. C., and Gonzalez, F. J. (1997). Role of PPARa in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643. Carcinogenesis, 18, 2029-33.
26. Pritchard, J. B., Brench, J. E., Davis, B. J., and Haseman, J. K. (2003). Transgenic mouse models. Their role in carcinogen identification. Environ Hlth Perspect 111, 444-54.
27. Russo, E. (2003). DNA microarrays hold much promise, but harbor many problems as well. Scientist 17, 30-1.
28. 2U-Urinary globulin associated ephropathy as a mechanism of renal tubule cell carcinogenesis in male rats. In Species Differences in Thyroid, Kidney and Urinary Bladder Carcinogenesis (C. C. Capen, E. Dybing, J. M. Rice, and J. D. Wilbourn, eds.), 147, 95-118. IARC Scientific Publications, Lyon, France.
29. Vineis, P., Caporaso, N., Tannenbaum, S. R., Skipper, P. L., Glogowski, J., Bartsch, H., Coda, M., Talaska, G., and Kadlubar, F. (1990). Acetylation phenotype, carcinogen-hemoglobin adducts, and cigarette smoking. Cancer Res 50, 3002-4.
30. Watson, J. D., and Crick, F. H. C. (1953). A structure for deoxyribose nucleic acid. Nature 171, 737.